Stock fact sheet · data as of
Cellebrite DI Ltd. (CLBT): fair value, margin of safety and Wheel Score
Ticker symbol CLBT · Technology · Software - Infrastructure · Israel · Growth
Is CLBT undervalued?
Cellebrite DI Ltd. (CLBT) closed at 12.43 on 5 Nov 2026, 15% above the GLS average fair value of 10.76. Only 4 of the 7 models that produced a number value the shares above the current price. The margin of safety is negative, so the stock fails the "below fair value" Wheel Trade Filter; a premium of this size is common for companies whose growth the models are conservative about.
There is a wide gap between EPV (2.64) and Payback Time (22.32). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
Ranked against every other company we cover, CLBT is clearly faster-growing than it is cheap, so the nightly engine files it under Growth (value score 24, growth score 81, out of 100).
Nine valuation models for CLBT
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | - | - | Present value of the projected free cash flows, discounted at the cost of capital; no value tonight |
| Graham Number | 3.41 | -73% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 13.57 | +9% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 5.93 | -52% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 14.53 | +17% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 12.94 | +4% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 22.32 | +80% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 2.64 | -79% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 0.4827 | -96% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 14.13 | +14% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Cellebrite DI Ltd. scores only 4 of 9 on the Piotroski F-score, which fails the "Piotroski 6 or more" Wheel Trade Filter. A reading this low means several of the basic tests - positive earnings, positive operating cash flow, falling debt, no new share issuance - are not met. On durability CLBT scores 5.8/10 on the GLS Moat - a middle reading; the Moat Score tab on the Quote page's Financials view shows which of the four parts hold it back.
Returns on capital are high - ROIC 15.4%, ROE 16.2%, ROA 8.3% - with debt at 0.05 times equity and a free-cash-flow yield of 4.5%.
Cellebrite DI Ltd. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Subscription Services 72%, Term Licenses 21%, Professional Services 7% (fiscal year FY2025).
Institutional ownership scores 6/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales; the last recorded insider buy was on 24 Sep 2026.
| Piotroski F-score | 4 / 9 | ROIC | 15.4% |
|---|---|---|---|
| GLS Moat | 5.8 / 10 | ROE | 16.2% |
| Debt / equity | 0.05 | ROA | 8.3% |
| Free-cash-flow yield | 4.5% | Payout ratio | 0% |
| Institutions | 6 / 10 | Insiders · Congress | 1 · 5 / 10 |
Wheel Score 31: Weak
With a Wheel Score of 31 Cellebrite DI Ltd. sits in the Weak band. It fails filter 3, below fair value - trades 15% above our fair value; and filter 4, financially healthy - Piotroski 4/9 (under 6); and filter 6, no serious red flags - Red Flags score 55 (under 60); Value (weak) is its weakest part.
Implied volatility is 61% on the near-the-money contracts 20-60 days out - above the 60% top of the sweet spot. It still passes the 25-80% filter, but the Wheel Score rewards it less because volatility this high usually comes with a reason. Chain open interest is 29,101 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 1.8M shares a day on a market cap of $3.1B, with a beta of 1.05; the Stability part of the Wheel Score rates that fair.
| Filter | Wheel Trade Filter | Result | Detail |
|---|---|---|---|
| 1 | Options that actually trade | Passes | Listed options with 1,000+ contracts of open interest and 100+ traded a day |
| 2 | A real business, not a gamble | Passes | Profitable over the last twelve months - not a speculative stock, fund or note |
| 3 | Below fair value | Fails | trades 15% above our fair value |
| 4 | Financially healthy | Fails | Piotroski 4/9 (under 6) |
| 5 | Can repay its debt | Passes | Long-term debt repaid from 3 years of operating cash flow or less (6 for real estate and utilities; banks and insurers are not judged on it) |
| 6 | No serious red flags | Fails | Red Flags score 55 (under 60) |
| 7 | A premium worth selling | Passes | Implied volatility 25-80% (enough premium, not a lottery ticket) |
| 8 | Big enough | Passes | Market cap $1 billion or more |
| 9 | Not a penny stock | Passes | Share price $5 or more |
| How it ranks | Rating | From | |
|---|---|---|---|
| Value | Weak | 15% above fair value | |
| Premium | Strong | implied volatility 61% | |
| Moat | Fair | moat 5.8/10 | |
| Health | Fair | Piotroski 4/9 | |
| Red Flags | Weak | Red Flags score 55/100 | |
| Option trading | Weak | 188 contracts a day, 29,101 open interest | |
| Stability | Fair | beta 1.05, $3.1B company |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.
Upcoming events
Cellebrite DI Ltd. reports earnings on 12 Nov 2026 (before the open) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Software - Infrastructure
The 12 companies below are the closest to Cellebrite DI Ltd. by market cap within the Software - Infrastructure industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| TDC Teradata Corporation | 34.61 | 103.17 | +66% | 82Good | $3.2B |
| NTCT NetScout Systems, Inc. | 38.10 | 34.54 | -10% | 34Weak | $2.8B |
| APPN Appian Corporation | 49.82 | 34.83 | -43% | 28Weak | $3.6B |
| AVPT AvePoint, Inc. | 16.90 | 12.24 | -38% | 35Weak | $3.6B |
| EEFT Euronet Worldwide, Inc. | 70.65 | 152.70 | +54% | 81Good | $2.6B |
| PAYO Payoneer Global Inc. | 7.16 | 7.97 | +10% | 27Weak | $2.4B |
| DLO Dlocal Limited | 13.90 | 32.03 | +57% | 57Fair | $4.1B |
| CORZZ Core Scientific, Inc. Tranche 2 Warrants | 12.89 | - | - | 11No options | $4.1B |
| CORZ Core Scientific, Inc. | 12.76 | - | - | 17Weak | $4.1B |
| PAY Paymentus Holdings, Inc. | 33.49 | 25.49 | -31% | 37Weak | $4.2B |
| FOUR Shift4 Payments, Inc. | 44.77 | 72.09 | +38% | 43Weak | $4.7B |
| DOX Amdocs Limited | 43.66 | 77.34 | +44% | 84Good | $4.7B |
Scan the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about CLBT
Is CLBT undervalued right now?
No: at 12.43 the stock trades 15% above the GLS average fair value of 10.76 (data as of 5 Nov 2026). The margin of safety is negative.
What is the Wheel Score of CLBT and what does it mean?
CLBT scores 31 out of 100 (Weak) - it fails Wheel Trade Filters 3, 4, 6. The Wheel Score ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned - in two parts: the 9 pass/fail Wheel Trade Filters (busy options, a real business, below fair value, Piotroski 6 or more, debt it can repay, a Red Flags score of 60 or more, implied volatility of 25-80%, a $1 billion company, $5 a share) and a ranking of how strongly a stock passes on value, premium, moat, health, red flags, option trading and stability. A stock that fails any filter stays under 70; 70-84 is Good, 85 and above is Prime. The Sunday Scan is the top 10 that pass, sorted by Wheel Score.
What is the GLS fair value for CLBT?
10.76 per share as of 5 Nov 2026 - the simple average of the 7 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Cellebrite DI Ltd. report earnings next?
The next earnings report is due on 12 Nov 2026 (before the open), 7 days from the data date of 5 Nov 2026. The Calendars page lists every upcoming report with its time of day.
Does CLBT have listed options, and how liquid are they?
Yes. The nightly snapshot found 24 listed contracts with 29,101 open interest across all expiries and implied volatility of 61% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.